CDKN2A and neoplasm: To prove the keratinocytic origin of VEGFR2-positive tumor cells and to evaluate differences in the subcellular localization of VEGFR2, we performed double immunofluorescence analyses with antibodies against p16INK4A to detect HPV-positive tumor cells and TP53 to detect HPV-negative tumor cells.